Processa Pharmaceuticals, Inc. (PCSA) — 分析师展望 / 分析师共识目标价为. 基于 5 位分析师评级, 共识为 看涨 — 4 买入, 1 持有.
分析师共识目标价为 $9.00, 上涨空间为 213.6% 相对于当前价格 $2.87.
分析师预估 每股收益(EPS)为 $-99.00 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-3.62 vs 预期 $-99.00 (超预期 +96.3%). 2025: 实际 $-10.36 vs 预期 $-10.25 (不及预期 -1.1%). 分析师准确度: 0%.
PCSA 股票 — 12个月价格预测
$9.00
▲ +213.59% 上涨空间
平均目标价
Based on 5 Wall Street analysts offering 12-month price targets for Processa Pharmaceuticals, Inc., the price target is $9.00.
平均目标价相对最新价格 $2.87 变动 +213.59%。
PCSA 分析师评级
Buy
基于过去3个月内 5 位分析师对 Processa Pharmaceuticals, Inc. 的评级
EPS 预测 — PCSA
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$3.62
vs Est –$99.00
▲ 2,634.8% off
2025
Actual –$10.36
vs Est –$10.25
▼ 1.1% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
营收预测 — PCSA
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
